John C. Reed

Executive

Johnson & Johnson Madrigal Pharmaceuticals, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 1 saleAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€2.7M

Latest filing published 18 Aug 2026 for Madrigal Pharmaceuticals, INC.. Read the official filing

Filing timeline

BuySale

John C. Reed

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

John C. Reed: trading record in brief

This profile gathers the share dealings of John C. Reed across 2 companies, led by Johnson & Johnson and Madrigal Pharmaceuticals, Inc. The record holds 8 filings, for trades running from 1 May 2024 to 15 August 2026.

On the market, this insider has only sold: 1 sale, €2.7M in total. Besides market trades, the filings include 1 share grant and 6 option exercises.

On 18 August 2026 came the latest disclosure, a share grant in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.